XML 37 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Business combinations (Tables)
9 Months Ended
Sep. 30, 2021
Business Combinations [Abstract]  
Schedule of Business Acquisitions, by Acquisition The preliminary Merger Date fair value of the consideration transferred consisted of the following:
 (in thousands)
Fair value of cash consideration$5,308,646 
Fair value of ordinary shares issued to acquiree stockholders5,658,126 
Fair value of replacement share-based awards issued to acquiree employees209,399 
Repayment of term loan obligations and accrued interest *865,800 
$12,041,971 
* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6 million from available cash to settle debt obligations that existed at the Merger Date.
Schedule of Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed
The following table summarizes the preliminary allocation of the consideration transferred based on management’s estimates of Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:

July 1,
2021
(in thousands)
Cash and cash equivalents$259,971 
Accounts receivable and unbilled revenue934,308 
Other current assets110,691 
Fixed assets, net162,988 
Operating lease right-of-use assets192,345 
Goodwill *8,013,878 
Intangible assets, net4,875,000 
Deferred tax assets172,229 
Other assets35,094 
Accounts payable(50,259)
Accrued expenses and other current liabilities(342,552)
Current portion of operating lease liabilities(38,371)
Unearned revenue(758,901)
Non-current portion of operating lease liabilities(157,658)
Non-current deferred tax liabilities(1,313,599)
Other non-current liabilities(53,193)
Net assets acquired$12,041,971 
* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is expected to be deductible for income tax purposes.

The following table summarizes the preliminary estimates of the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):
Estimated Fair ValueEstimated Useful Life
Customer relationship3,905,000 23 years
Order backlog489,000 3 years
Trade names202,000 3 years
Patient database168,000 7 years
Technology111,000 5 years
4,875,000 
The following table summarizes the Company’s fair values of the assets acquired and liabilities assumed:
January 22,
2020
(in thousands)
Cash & cash equivalents$10,170 
Property, plant and equipment45 
Operating right of use assets539 
Goodwill *27,191 
Customer relationships 11,725 
Order backlog 2,883 
Accounts receivable3,033 
Prepayments and other current assets 158 
Accounts payable(368)
Unearned revenue(989)
Other liabilities(2,202)
Current lease liabilities(219)
Non-current lease liabilities(320)
Non-current deferred tax liability(4,090)
Net assets acquired$47,556 
Cash outflows$46,992 
Working capital adjustment paid564 
Contingent consideration **— 
Total consideration$47,556 
* Goodwill represents the acquisition of an established workforce that specializes in medical device development and market access. None of the goodwill recognized is expected to be deductible for income tax purposes.
** The fair value of the contingent consideration was estimated at the date of acquisition as $Nil. Depending on performance of MedPass for the 12 month period ended December 31, 2020, the total consideration could have increased by a maximum of $6.7 million in contingent consideration. In January 2021, the contingent consideration was finalized and a value of $Nil was payable.
Business Acquisition, Pro Forma Information
The following pro forma financial information was derived from the historical financial statements of the Company and PRA and presents the combined results of operations as if the Merger had occurred on January 1, 2020. The pro forma financial information is presented for comparative purposes only and is not necessarily indicative of the results that would have actually occurred had the Merger been completed on January 1, 2020. In addition, the pro forma financial information does not give effect to any anticipated cost savings, operating efficiencies or other synergies that may result from the Merger, or any estimated costs that have been or will be incurred by the Company to integrate the assets and operations of PRA. Consequently, actual future results of the Company will differ from the pro forma financial information presented below:
Nine months endedYear ended
September 30December 31
20212020
(in thousands, except per share data)
Revenue$5,580,879 $5,964,653 
Net income/(loss)$231,442 $(151,209)